FDA should embrace new ways of evaluating rare disease drugs, report argues

To increase the pace of rare disease drug approvals, the FDA should embrace nontraditional data, deploy new forms of analysis and be more open about …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Food for thought: Mediterranean-DASH intervention shows positive impact on brain health

Researchers investigated the longitudinal relationships between adherence to the Mediterranean-dietary approaches.

July 20, 2023

Senators call on FDA to address ‘deluge of misleading promotions’ on social media

Senators across both sides of the aisle are calling for a “swift” update to the FDA’s guidance on prescription drug promotion. Sens. Mike Braun (R-IN)

February 17, 2024

SYNLAB invests in innovative Healthcare Centre in Florence – Biotech Investments

EQS-News: SYNLAB AG / Key word(s): Expansion SYNLAB AG: SYNLAB invests in innovative Healthcare Centre in Florence 28.06.2023 / 07:30 CET/CEST The issuer is solely

June 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.